In the fall edition of the Class Action & MDL Roundup, covering notable class actions from the third quarter of 2021, a marriage nearly tears apart a certified class, insurers are vaccinated against more COVID-19 suits, and ERISA shifts the burden of proof. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Class Action MDL Roundup
Fall 2021
Class Action & MDL Roundup – Fall 2021
-
Cari K. Dawson
-
David Venderbush
-
Ryan P. Ethridge
-
Alexander Akerman
-
Gina Angiolillo
-
David Carpenter
-
F. Nicholas Chandler
-
Sean R. Crain
-
R. Blake Crohan
-
Jamie S. George
-
Bradley Harder
-
Kara F. Kennedy
-
Laura A. Komarek
-
Matthew D. Lawson
-
Andrew J. Liebler
-
Melissa Quintana
-
William J. Repko III
-
Noelle Reyes
-
Jason Rottner
-
Troy A. Stram
-
Andrew T. Sumner
-
Amanda M. Waide
Meet the Authors
Senior Associate
Phone:
+1 404 881 7969
Other Phone:
+1 212 905 9156
Email:
nick.chandler@alston.com
Related News & Insights
-
Class Action MDL Roundup July 2, 2024Class Action & MDL Roundup 2024 Q1 – Reaching across the pondIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2024, UK High Court weighs in on information asymmetry, debit is better than credit, and it helps to have a credible plaintiff. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup December 18, 2023Class Action & MDL Roundup 2023 Q3 - Catching the class action waive(r)In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the third quarter of 2023, a mistake is just a mistake, “99.99%” isn’t 100% clear, and faxes aren’t always free. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup September 29, 2023Class Action & MDL Roundup 2023 Q2 – Ascertainability lives!In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2023, essential oils may need therapy, an ever-growing library goes nowhere, and one exclusion is specifically ambiguous. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup June 30, 2023Class Action & MDL Roundup 2023 Q1 – We don’t discount confidentialityIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2023, in pork we antitrust, paid time off is not pay, and if it’s free, it won’t cost you a TCPA violation. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup March 27, 2023Class Action & MDL Roundup 2022 Q4 – A “healthy” dose of litigationIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the fourth quarter of 2022, class actions gain an international flair, insurers have cures for COVID cases, and a remote presence is still a presence. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Media Contact